AMD CEO Forecasts FiveYear CPU Demand Surge Calling Current Growth Unexpected Quad Foreign Ministers Meet in New Delhi to Strengthen IndoPacific Cooperation Amid Geopolitical Shifts Paychex Stock Wall Street Analysts Share Price Targets Amid Mixed Outlook Legal Case Dismissal for Kilmar Abrego Garcia Could Signal Shift in Immigration Enforcement Dynamics Saudi Arabias Vision 2030 Spending Spree Meets Fiscal Reality Space Stocks Rally as SpaceXs Latest Starship Test Fuels PreIPO Speculation EWBC Q1 2026 Earnings EPS Surpasses Estimates Amid Solid Operating Performance SOWG Q3 2025 Earnings Significant EPS Miss Amid Challenging Quarter Gaming and Leisure Properties Inc GLPI Q1 2026 Earnings EPS Slightly Misses Estimates Modest Stock Uptick Enbridge Q1 2026 Earnings EPS Beats Estimates Amid Broader Market Weakness RWT Q1 2026 Earnings EPS Misses Estimates Stock Declines Slightly Loews Corporation Q1 2026 Earnings Solid EPS Amid Mixed Segment Performance Tempus AI Inc TEM Modestly Higher as It Holds Near Key Support Ocular Therapeutix OCUL Slips Slightly as Stock Holds Key Support at 775 Epsilon Energy Ltd EPSN Edges Higher Amid Consolidation Phase BIOkey International BKYI Declines 44 as Selling Pressure Persists Near Key Support Immix Biopharma IMMX Edges Lower in Consolidation Phase Eyes Key Support at 829 Fed Rate Hike Odds Rising Prediction Markets Point to July 2027 Increase Flanigans Enterprises Inc BDL Q3 2025 Earnings Positive EPS Performance Despite Lack of Consensus Estimates Valero Energy VLO Rallies 243 as Support Holds and Sector Sentiment Improves Why Generation GIPR deserves more attention from serious investors 297 20260507 Rush RSI Stock Prediction Q4 2025 Profit Disappoints ONCY Oncolytics Biotech Inc Common Shares posts wider Q3 2025 loss than consensus estimates shares rise 566 percent How CoStar CSGP manages its cash position Q1 2026 EPS Beats Forecasts Moderna Inc MRNA mRNA Platform Diversification Gains Momentum with Phase 3 Flu Success and Hantavirus Advancement BBIO BridgeBio revenue soars 126 yearoveryear in Q1 2026 offsetting earnings miss shares little changed EMN Eastman Chemical Company posts Q4 2025 EPS beat shares drop 141 percent on 67 percent year over year revenue decline